Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record.

NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection

Open access
See, I., Mu, Y., Cohen, J., Beldavs, Z. G., Winston, L. G., Dumyati, G., Holzbauer, S., Dunn, J., Farley, M. M., Lyons, C., Johnston, H., Phipps, E., Perlmutter, R., Anderson, L., Gerding, D. N., Lessa, F. C. · 2014 · Clinical Infectious Diseases

Abstract

BACKGROUND: Studies are conflicting regarding the importance of the fluoroquinolone-resistant North American pulsed-field gel electrophoresis type 1 (NAP1) strain in Clostridium difficile infection (CDI) outcome. We describe strain types causing CDI and evaluate their association with patient outcomes. METHODS: CDI cases were identified from population-based surveillance. Multivariate regression models were used to evaluate the associations of strain type with severe disease (ileus, toxic megacolon, or pseudomembranous colitis within 5 days; or white blood cell count ≥15 000 cells/µL within 1 day of positive test), severe outcome (intensive care unit admission after positive test, colectomy for C. difficile infection, or death within 30 days of positive test), and death within 14 days of positive test. RESULTS: Strain typing results were available for 2057 cases. Severe disease occurred in 363 (17.7%) cases, severe outcome in 100 (4.9%), and death within 14 days in 56 (2.7%). The most common strain types were NAP1 (28.4%), NAP4 (10.2%), and NAP11 (9.1%). In unadjusted analysis, NAP1 was associated with greater odds of severe disease than other strains. After controlling for patient risk factors, healthcare exposure, and antibiotic use, NAP1 was associated with severe disease (adjusted odds ratio [AOR], 1.74; 95% confidence interval [CI], 1.36-2.22), severe outcome (AOR, 1.66; 95% CI, 1.09-2.54), and death within 14 days (AOR, 2.12; 95% CI, 1.22-3.68). CONCLUSIONS: NAP1 was the most prevalent strain and a predictor of severe disease, severe outcome, and death. Strategies to reduce NAP1 prevalence, such as antibiotic stewardship to reduce fluoroquinolone use, might reduce CDI morbidity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciu125

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 170

Metadata

Authors
See, I., Mu, Y., Cohen, J., Beldavs, Z. G., Winston, L. G., Dumyati, G., Holzbauer, S., Dunn, J., Farley, M. M., Lyons, C., Johnston, H., Phipps, E., Perlmutter, R., Anderson, L., Gerding, D. N., & Lessa, F. C.
Venue
Clinical Infectious Diseases
Published
2014-03-05
Volume
58
Issue
10
Pages
1394-1400
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2132075236
Cited by
170
References
0
FWCI
17.31
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection. https://app.cochat.ai/papers/10.1093/cid/ciu125
The paper
See, I., Mu, Y., Cohen, J., Beldavs, Z. G., Winston, L. G., Dumyati, G., Holzbauer, S., Dunn, J., Farley, M. M., Lyons, C., Johnston, H., Phipps, E., Perlmutter, R., Anderson, L., Gerding, D. N., & Lessa, F. C. (2014). NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciu125

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.